Microfluidic apoptosis chip for drug screening to improve and personalize cancer therapy


Share/Save/Bookmark

Wolbers, F. and Franke, H.R. and Andersson-Svahn, S.M.H. and Vermes, I. and Berg, A. van den (2008) Microfluidic apoptosis chip for drug screening to improve and personalize cancer therapy. In: Highlights in Biomedical Technology 2008, 20 Nov 2008, Enschede (pp. pp. 101-104).

[img] PDF
Restricted to UT campus only
: Request a copy
471kB
Abstract:Currently, the knowledge on breast cancer treatment is increasing, however, there are still
hardly any assays present to match patients to the right form of therapy to enhance the
therapeutic effectiveness. Therefore a microfluidic device is developed to analyse the
hormonal and chemosensitivity of first breast cancer cell lines and in a later stage a patient’s
own tumour cells. As the main goal of breast cancer therapy is to kill tumour cells, the degree
of apoptosis is assessed.
Item Type:Conference or Workshop Item
Faculty:
Electrical Engineering, Mathematics and Computer Science (EEMCS)
Research Group:
Link to this item:http://purl.utwente.nl/publications/62712
Export this item as:BibTeX
EndNote
HTML Citation
Reference Manager

 

Repository Staff Only: item control page

Metis ID: 256142